On March 8, 2023 aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, reported that the company will present at two upcoming investor conferences scheduled to take place in March 2023 (Press release, aTyr Pharma, MAR 8, 2023, View Source [SID1234628345]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentations appear below:

Conference: 35th Annual Roth Conference
Date: Tuesday, March 14, 2023
Time: 10:00am PDT
Location: Dana Point, CA
Format: Fireside Chat

Conference: Oppenheimer 33rd Annual Healthcare Conference
Date: Wednesday, March 15, 2023
Time: 10:00am EDT
Location: Virtual
Format: Corporate Presentation

In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the conferences. A webcast and replay of the Corporate Presentation will be available on the Investor’s section of the company’s website at www.atyrpharma.com. For more information, please contact [email protected].